文献速递眼底病与葡萄膜炎

近视性牵拉性黄斑病变的手术管理:近视学会专家观点

Surgical management of myopic traction maculopathy; expert perspectives from the myopia society.
PubMed 文献 · Prog Retin Eye Res · 2026-01-03

近视性牵拉性黄斑病变(MTM)见于约9-34%的高度近视眼,需手术防止进展为黄斑裂孔或视网膜脱离导致不可逆视力丧失。本文按视网膜劈裂、中心凹视网膜脱离、板层黄斑裂孔、全层黄斑裂孔四类核心病变分类,提出治疗决策算法。

要点

  • MTM按四种核心病变分类:视网膜劈裂、中心凹视网膜脱离、板层黄斑裂孔、全层黄斑裂孔。
  • 中心凹视网膜脱离伴进行性视力下降或黄斑裂孔视网膜脱离应及早行PPV。
  • 复发MTM无全层黄斑裂孔时追加ILM剥除,有全层黄斑裂孔时用ILM瓣等技术手术。

核心结论

  • MTM手术需根据病变位置个体化制定方案,共同目标是处理视网膜上的牵拉组织。
  • PPV能可靠去除牵拉组织,应及时用于中心凹视网膜脱离伴进行性视力下降或黄斑裂孔视网膜脱离患者。
  • 复发MTM常见原因为膜剥除不充分,需宽场成像和更 intensive 的术中评估残留组织。

研究设计与样本

  • 本文为近视学会专家观点,将MTM分为四种核心病变并提出治疗决策算法。
  • 原文未报告系统检索范围或样本量。

主要发现

  • MTM发生于约9-34%的高度近视眼。
  • 术后需密切监测黄斑裂孔发生或黄斑萎缩进展。
  • 复发MTM无全层黄斑裂孔时追加ILM剥除,有全层黄斑裂孔时采用ILM瓣、自体视网膜瓣或羊膜移植等技术手术。
  • 黄斑扣带术单独或联合PPV也有报道有效。
  • 治疗后需长期随访监测恢复和复发。

关键数值与推荐

  • 中心凹视网膜脱离伴进行性视力下降或黄斑裂孔视网膜脱离应及早行PPV。
  • 复发MTM无全层黄斑裂孔时追加ILM剥除。
  • 复发MTM伴全层黄斑裂孔时采用ILM瓣、自体视网膜瓣或羊膜移植等技术手术。
  • 黄斑扣带术可单独或联合PPV使用。

临床怎么用

  • 根据MTM病变位置(视网膜劈裂、中心凹视网膜脱离、板层黄斑裂孔、全层黄斑裂孔)选择手术方案。
  • 对中心凹视网膜脱离伴进行性视力下降或黄斑裂孔视网膜脱离患者及时行PPV。
  • 复发MTM需宽场成像和术中更 intensive 评估残留组织,并据此选择追加ILM剥除或ILM瓣等技术。
  • 术后长期随访监测黄斑裂孔、黄斑萎缩进展和复发。

局限性

  • 原文指出仍需随机前瞻性试验进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Myopic traction maculopathy (MTM) occurs in approximately 9-34 % of highly myopic eyes and requires surgical treatment to prevent irreversible vision loss due to progression to macular hole (MH) or retinal detachment (RD). While treatment of MTM, which presents with a variety of morphological patterns, shares the common goal of managing the causative tractional tissues on the retina, it is essential to tailor the surgical plan according to the locations of each lesion. Here, we classify MTM into four core lesions: retinoschisis, foveal RD, lamellar MH (LMH), and full-thickness MH (FTMH), and present an algorithm for treatment decision-making. Pars plana vitrectomy (PPV) is a procedure that enables reliable removal of traction-inducing tissues and should be promptly indicated for patients with foveal RD showing progressive vision decline or those with MHRD. Postoperatively, development of macular hole or progression of macular atrophy should be monitored carefully. In recurrent MTM, inadequate membrane peeling is a common cause, requiring wide-field imaging and more intensive intraoperative assessment for residual tissues. Recurrent MTM without FTMH is treated with additional ILM peeling, while recurrence with FTMH is managed surgically using techniques involving ILM flaps, autologous retinal flap, or amniotic membrane transplantation. Macular buckling has also been reported to be effective when used alone or in combination with PPV. Following treatment, long-term follow-up is essential for monitoring both recovery and recurrence. Though further validation through randomized prospective trials is needed, the paradigm for MTM surgery continues to evolve toward preventing persistent vision loss and to optimizing long-term outcomes.

来源:Prog Retin Eye Res,查看原文。版权归原作者所有。

引用

  1. Takahashi H, Spaide RF, Lee SY, et al. Surgical management of myopic traction maculopathy; expert perspectives from the myopia society. Prog Retin Eye Res. 2026. PMID: 41490771. doi:10.1016/j.preteyeres.2025.101434

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。